Click here to visit SME Buzz - A Business Standard special on the latest news, information and features on Small and Medium business  
   
Business Standard
Saturday, Mar 20, 2010
Budget 2010 Sponsored by
drived banner
drived banner
  Advanced Search
Feedback | RSS
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Smart Portfolios II
  Search:

US FDA nod for Ranbaxy's anti-seizure drugs
BS Reporter / New Delhi March 30, 2009, 12:24 IST

Ranbaxy Laboratories - the country's largest drug maker -has gained final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) to market and manufacture Topirimate tablets 25mg, l0Omg & 200mg for treating seizures. 

 Click here to visit SME Buzz
 
 
News Now
Paper
Specials
- Markets close to 2-year high
- HP inks strategic deal with Polycom, abandons Tandberg
- For Google stock, China could mark turning point
- Doha talks not at their expected stage: Sharma
- NEWSALERT: No immediate hike in lending rates, says O P Bhatt
More  

The application for the drug was submitted by Ranbaxy from the Ohm Laboratories manufacturing facility, located in North Brunswick, New Jersey, USA.
 
Ohm, based in North Brunswick, New Jersey, USA, is a wholly owned subsidiary of Ranbaxy Laboratories Ohm is engaged in the sale and distribution of generic and branded private label, OTC products in the US healthcare system.

Arrow Other Stories     
- Markets close to 2-year high
- HP inks strategic deal with Polycom, abandons Tandberg
- For Google stock, China could mark turning point
- Doha talks not at their expected stage: Sharma
- NEWSALERT: No immediate hike in lending rates, says O P Bhatt
More  
  Read Business news in 
  
  
  
   " Instant Loan for Corporates"
   Get a complementary DLF IPL Ticket worth Rs500
  
   An IT infrastructure that meets increased business demands without increase in costs
   Transfer your funds at ease from abroad
  
   Get triple tax benifits, and doosra income Advantage
   Now Pick your advisor with ING Life Insurance
  Replace your aging IT hardware and dramatically lower your IT operating expense
  Tata AIG Health Insurance - Complete Health Cover with Tax Savings.
  Reduce cost and increase profitability.. know more
  Overcome IT challenges & exceed business expectations with a simple click
  
  Giftwithlove.com: Same Day Gifts & Flowers Delivery to India
   Discussion Board / User Comments    
Display Name  Email-Id  
Post your comment
Most Popular
Read
E-Mailed
Commented
   
- RBI raises repo, reverse repo
- IPL may get 6 bidders for 2 new teams
- Ivy League may not line up for an Indian campus
- Indian Punters League cashes in on IPL-3
- Only old faces in 3G fray
 
 More  
BS Poll
Cast Your Vote
 
   
 
Should FDI be permitted in India's nuclear sector?
  Yes  No
Submit

  Hot Searches  
 
Budget 2010 |  Railway Budget |  Economic Survey |  Bharti |  Ranbaxy |  Auto sales |  My Name Is Khan |  CAT  |  Maruti Suzuki |  Small Car |  Dubai |  BSE  |  NSE |  Amitabh Bachchan |  Mukesh Ambani |  Anil Ambani |  Bollywood |  TCS |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Congress |  Rahul Gandhi |  New Pension Scheme |  Service tax |  Excise duty |  Sebi |  Notebook |  Tech Mahindra |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |   |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  World Bank |  HDFC  |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Site Map | Contact Us | Feedback